Authors
D. A. Fadeeva
candidate of pharmaceutical sciences, senior lector of the Department of pharmaceutical chemistry and pharmacognosy of The National Research University «Belgorod State University», e-mail: fadeeva_d@bsu.edu.ru
Abstract
The article presents the results of studies on the development of composition and technology of complex eye drops with taurine and carnosine. The data on the selection of excipients is represented. Approved the selection of the active ingredients. The release of drugs from the dosage form was studied. The technology of production of eye drops was represented.
Key words
eye drops, carnosine, taurine, prolongated dosage forms
References
1. Boldyrev A.A. Carnosine. The biological significance and applications in medicine. Moscow: MSU Publ., 1998. 320 p.
2. Russian Federation Pharmacopoeia 13. General monograph 1.4.1.0003.15. Eye dosage forms OFS.
3. Lumpova, T.N. The use of eye drops Oftan Katahrom for the treatment of complicated cataract with glaucoma. Klinicheskaja oftalmologija, Vol. 8, ¹ 4 (2007). http://www.rmj.ru/articles_5623.htm.
4. Majchuk J.F. Taufon (taurine) in the treatment of eye diseases. Review. Kataraktalnaja i refrakcionnaja hirurgija, Vol. 11, ¹ 1 (2011): 56-61.
5. Sakaeva I.V. et al. Determining the requirements for a number of sterile dosage forms. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Serija: Medicina. Farmacija, Vol.18, ¹ 10-2(129) (2012): 70-75.
6. Fadeeva D.A. et al. Studying of physical and chemical properties of prolongators for ophtalmic medicinal forms. Kubanskij nauchnyj medicinskij vestnik, ¹ 3 (2009): 132-135.
7. Fadeeva D.A. et al. Study of trans-resveratrol’s solubility. Sovremennye naukoemkie lechebnye i farmacevticheskie tehnologii dlja oftal'mologii: Sbornik materialov Vseross. shkoly-seminara, Belgorod (2009): 140-145.
8. Fadeeva D.A. et al. Estimation of antioxidant activity of some aminoacids, peptides and polyphenols in vitro. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Serija: Medicina. Farmacija, ¹ 4(99) (2011): 178-181.
9. Fadeeva D.A. et al. Toxicological study of new antycataract eye drops. Nauchnye vedomosti BelGU. Serija Medicina. Farmacija, ¹ 10(81) (2010): 93–96.
10. Chylack L.T. Jr. et al The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age–related cataract. Ophthalmic Epidemiol. Vol.9. (2002): 49-80.
11. Doganay S. et al The effect of resveratrol in experimental cataract model formed by sodium selenite. Curr Eye Res. Vol. 31(2). (2006): 147-153.
12. Gritz D.C. Can cataracts be prevented? Bulletin of the World Health Organization. Vol. 79. (2001): 260-261.
